ACADIA PHARMACEUTICALS INC. Class of Warrant or Right, Outstanding
ACADIA PHARMACEUTICALS INC. (ACAD) had Class of Warrant or Right, Outstanding of 493.14 thousand shares as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2020-02-27
- 2019-12-31: Class of Warrant or Right, Outstanding 493.14K shares.
- 2012-12-31: Class of Warrant or Right, Outstanding 500.00K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2019-12-31 | 493.14K shares 10-K · filed 2020-02-27 |
| 2012-12-31 | 500.00K shares 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |